Company Profile

Theraneutrics LLC
Profile last edited on: 5/29/2021      CAGE: 8DN78      UEI: HE5AH1LKAUA3

Business Identifier: Engineered probiotics for gout patients
Year Founded
2018
First Award
2020
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1938 Harney Street Suite 247
Laramie, WY 82072
   (307) 340-1616
   info@theraneutrics.com/
   www.theraneutrics.com/
Location: Single
Congr. District: 00
County: Albany

Public Profile

Developing nutraceuticals that will improve the quality of life of those suffering from gout, Theraneutrics is developing Krystalase, a patent-pending probiotic yeast strain supplement specifically engineered to that population. Designed to be affordable, accessible, and broadly effective. Krystalase is a next-generation probiotic supplement: engineered probiotics designed to address the root cause of gout - excessive uric acid in the blood of the patient

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 1 NSF $264,840
Project Title: Engineering probiotic yeast to treat hyperuricemia and gout

Key People / Management

  Christoph Geisler -- Co-Founder and CSO